Panama enhances newborn protection against severe RSV complications

Panamanian health authorities are intensifying efforts to shield newborns from the severe effects of the respiratory syncytial virus (RSV), a common pathogen that poses significant risks to infants.

RSV inflames and clogs the smallest airways, impeding airflow to the lungs. While often presenting as a mild, cold-like illness, it can escalate to severe respiratory distress in newborns, necessitating oxygen support, intensive care, and mechanical ventilation.

Edgardo Ureña, head of child health at the Ministry of Health (Minsa), explained that while RSV typically causes mild symptoms in the general population, it can progress to moderate or severe cases in infants under one year old, the elderly, and individuals with chronic health conditions.

“

Respiratory syncytial virus causes respiratory tract diseases, which in most cases are mild, similar to a cold, however, in children under one year of age, in adults and in people with important chronic diseases, they can progress to moderate and severe cases.

Preventive measures recommended by specialists include frequent hand washing, respiratory etiquette (covering coughs and snees), mask-wearing when symptomatic, and avoiding contact with newborns if ill. A key strategy involves vaccinating pregnant individuals between 30 and 36 weeks gestation. This allows antibodies to transfer to the fetus, providing crucial protection during the baby's first few months.

Furthermore, starting in late August, Panama will begin administering a monoclonal antibody to newborns. This preventative treatment provides pre-made antibodies designed to block the virus, significantly reducing the risk of severe illness, hospitalization, and complications during the RSV season. Pediatric infectious disease specialist Raúl Esquiviel noted that this antibody offers protection for at least six months, with studies suggesting longer efficacy.

“

I administer that medication which is an antibody, they are the defenses that he will not have to produce and that will protect him for six months, and there are even studies that have already shown that protection extends beyond six months.